Title | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Chirocaince (Levobupivacaine) Injection, 2.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials, 5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials and 7.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials |
ToC Doc | Chirocaince (Levobupivacaine) Injection, 2.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials, 5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials and 7.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials |
Docket Number | 2023-11162 |
Type | Notice |
Subject | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Chirocaince (Levobupivacaine) Injection, 2.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials, 5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials and 7.5 Milligrams (Base)/Milliliter, 10 Milliliter and 30 Milliliter Vials |
Publication Date | 2023-05-25 |
Last Updated Date | 2023-05-24 08:15:10 -0400 |
Last Public Inspection | 2023-05-24 |
Filed At | 2023-05-24T08:45:00.000-04:00 |
2023-11162_PI.pdf (95078 bytes) | |
Download | TXT / HTML / JSON |
Number of Pages | 4 |
Filing Type | regular |
Agencies | Food and Drug Administration |
You can find the raw source document below...